
Sign up to save your podcasts
Or


In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.
Kristen Mittal LinkedIn
Mridul Mittal LinkedIn
Mittal Consulting LinkedIn
Mittal Consulting Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Project Medtech Website
By Project Medtech5
2323 ratings
In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.
Kristen Mittal LinkedIn
Mridul Mittal LinkedIn
Mittal Consulting LinkedIn
Mittal Consulting Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Project Medtech Website

30,711 Listeners

4,168 Listeners

1,288 Listeners

4,350 Listeners

9,572 Listeners

92 Listeners

9,530 Listeners

1,423 Listeners

226 Listeners

68 Listeners

6,094 Listeners

9,935 Listeners

444 Listeners

15,261 Listeners

1,660 Listeners